Barr Pharmaceuticals

From Wikipedia, the free encyclopedia - View original article

Barr Pharmaceuticals Inc
IndustryPharmaceuticals & Medical Devices
FoundedNew York (1970)
HeadquartersMontvale, NJ, USA
Key peopleBruce Downey, CEO
ProductsGeneric and Proprietary Pharmaceuticals
RevenueOver $1 Billion USD fiscal year 2005
Employees2000
ParentTeva Pharmaceutical Industries
Websitehttp://www.tevapharm.com/
 
Jump to: navigation, search
Barr Pharmaceuticals Inc
IndustryPharmaceuticals & Medical Devices
FoundedNew York (1970)
HeadquartersMontvale, NJ, USA
Key peopleBruce Downey, CEO
ProductsGeneric and Proprietary Pharmaceuticals
RevenueOver $1 Billion USD fiscal year 2005
Employees2000
ParentTeva Pharmaceutical Industries
Websitehttp://www.tevapharm.com/

Barr Pharmaceuticals was a global specialty pharmaceutical company that operated in more than 30 countries worldwide. Barr was engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals, and active pharmaceutical ingredients.

History[edit]

Barr Laboratories Inc. was founded in 1970 by Stanley Benerofe and Edwin A. Cohen and was ultimately taken public under their leadership.

On July 18, 2008; it was announced that rival firm, Teva Pharmaceutical Industries Ltd. would acquire Barr Pharmaceuticals Inc. for $7.46 billion plus the assumption of net debt of approximately $1.5 billion.[1] Today Barr Laboratories exists only as a sub-division of Teva Pharmaceuticals, as part of the Teva Active Pharmaceutical Ingredients (TAPI) division.

Teva Pharmaceuticals develops and markets generic pharmaceuticals under various brand names, including the Barr Laboratories, Inc. label. Teva Pharmaceuticals is the largest generic drug manufacturer in the world.

References[edit]

  1. ^ Staff (2008-07-21), "Teva Coughs Up $7.46B for Barr Reinforcing Its Number One Spot in the Generics Market", Genetic Engineering & Biotechnology News, GEN News Highlights (Mary Ann Liebert), ISSN 1937-8661, retrieved 2008-09-26